Developing Policy Infrastructure to Guide Genomics-Informed Oncology Nursing in Canada: An Interpretive Descriptive Study.

Genomics nurse education nursing oncology policy

Journal

The Canadian journal of nursing research = Revue canadienne de recherche en sciences infirmieres
ISSN: 1705-7051
Titre abrégé: Can J Nurs Res
Pays: United States
ID NLM: 8910581

Informations de publication

Date de publication:
09 May 2024
Historique:
medline: 9 5 2024
pubmed: 9 5 2024
entrez: 9 5 2024
Statut: aheadofprint

Résumé

Genomic technologies such as genetic testing and precision treatments are rapidly becoming routine in oncology care, and nurses play an increasingly important role in supporting the growing demands for genomics-informed healthcare. Policy infrastructure such as competencies, standards, scope of practice statements, and education and curriculum frameworks are urgently needed to guide these practice and education changes. This study is part of a larger three-phase project to develop recommendations and catalyze action for genomics-informed oncology nursing education and practice for the Canadian Association of Nurses in Oncology and the Canadian Association of Schools of Nursing. This phase aimed to enhance understanding of policy needs and action drivers for genomics-informed oncology nursing education and practice through the perspectives of Canadian oncology nurses and patient partners. Interpretive description methodology guided the study. Twenty semi-structured virtual interviews were conducted; 17 with oncology nurses in various domains of practice, and three with patient partner representatives. Data collection and analysis occurred concurrently. Our analysis identified three themes: 1) nurses and patients recognize that it is time for action, 2) nurses and patients see advantages to executing intentional, strategic, and collaborative policy development, and 3) leadership and advocacy are required to drive action. Nursing policy infrastructure is required to increase genomic literacy, support nurses in providing safe patient care, and establish clear roles, responsibilities, and accountabilities within the interdisciplinary team. Strong leadership and advocacy at the practice, organizational, and systems levels are vital to accelerating action.

Sections du résumé

BACKGROUND BACKGROUND
Genomic technologies such as genetic testing and precision treatments are rapidly becoming routine in oncology care, and nurses play an increasingly important role in supporting the growing demands for genomics-informed healthcare. Policy infrastructure such as competencies, standards, scope of practice statements, and education and curriculum frameworks are urgently needed to guide these practice and education changes.
PURPOSE OBJECTIVE
This study is part of a larger three-phase project to develop recommendations and catalyze action for genomics-informed oncology nursing education and practice for the Canadian Association of Nurses in Oncology and the Canadian Association of Schools of Nursing. This phase aimed to enhance understanding of policy needs and action drivers for genomics-informed oncology nursing education and practice through the perspectives of Canadian oncology nurses and patient partners.
METHODS METHODS
Interpretive description methodology guided the study. Twenty semi-structured virtual interviews were conducted; 17 with oncology nurses in various domains of practice, and three with patient partner representatives. Data collection and analysis occurred concurrently.
RESULTS RESULTS
Our analysis identified three themes: 1) nurses and patients recognize that it is time for action, 2) nurses and patients see advantages to executing intentional, strategic, and collaborative policy development, and 3) leadership and advocacy are required to drive action.
CONCLUSION CONCLUSIONS
Nursing policy infrastructure is required to increase genomic literacy, support nurses in providing safe patient care, and establish clear roles, responsibilities, and accountabilities within the interdisciplinary team. Strong leadership and advocacy at the practice, organizational, and systems levels are vital to accelerating action.

Identifiants

pubmed: 38721630
doi: 10.1177/08445621241252615
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

8445621241252615

Déclaration de conflit d'intérêts

Declaration of conflicting interestsThe authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Auteurs

Patrick Chiu (P)

Faculty of Nursing, University of Alberta, Edmonton, Canada.

Jacqueline Limoges (J)

Faculty of Health Disciplines, Athabasca University, Athabasca, Canada.
Ontario Cancer Research Ethics Board, Toronto, Canada.

Rebecca Puddester (R)

Faculty of Nursing, Memorial University of Newfoundland, St. John's, Canada.

Andrea Gretchev (A)

Faculty of Health Disciplines, Athabasca University, Athabasca, Canada.

Lindsay Carlsson (L)

Princess Margaret Cancer Centre, Toronto, Canada.

Kathleen Leslie (K)

Faculty of Health Disciplines, Athabasca University, Athabasca, Canada.

Don Flaming (D)

Canadian Association of Schools of Nursing, Ottawa, Canada.

Ann Meyer (A)

BioInnovation Scientist Program, adMare BioInnovations, Toronto, Canada.

April Pike (A)

Faculty of Nursing, Memorial University of Newfoundland, St. John's, Canada.

Classifications MeSH